Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 3/2017

20.02.2017

Disproportional increase of pulmonary embolism in young females in Germany: trends from 2005 to 2014

verfasst von: F. Santosa, Ch. Moerchel, Ch. Berg, K. Kröger

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

We analysed the number of pulmonary embolism (PE) in young females aged 10–39 years in the period from 2005 to 2014 in Germany to see any trends that possibly may reflect some influences of newer oral contraceptives. Detailed lists of all hospitalized cases with the principal diagnosis PE coded as I26 in the years 2005–2014 were provided by the Federal Statistical Office. In males, the absolute number of all hospitalized cases with the principal diagnosis PE increased from 16,066 in 2005 to 25,364 in 2014 (rate +57.8%) and in females from 21,548 to 29,433 (rate +36.5%). The annual differences in PE between males and females decreased from 5482 to 4069 (−26%) in this period. In the age group of 10–39 years the absolute number of all hospitalized male cases increased from 1023 in 2005 to 1276 in 2014 (+24.7%) and in females from 1341 to 1949 (rate +45.3%). Thus in contrast to the overall trend the annual difference in PE rose gradually by 112% (from 318 to 673) from 2005 to 2014. Our ecologic nationwide analysis of hospitalization rates for PE shows that the annual differences between males and females cases hospitalized with the principal diagnosis PE in general decreased, but increased in the age group of 10–39 years in the last decade.
Literatur
1.
Zurück zum Zitat Moysidis T, Kröger K, Moerchel C, Santosa F, Gröchenig E (2010) Pulmonary embolism in young males and females in Germany: data from the Federal Statistical Office. Blood Coagul Fibrinolysis 21:511–515CrossRefPubMed Moysidis T, Kröger K, Moerchel C, Santosa F, Gröchenig E (2010) Pulmonary embolism in young males and females in Germany: data from the Federal Statistical Office. Blood Coagul Fibrinolysis 21:511–515CrossRefPubMed
2.
Zurück zum Zitat Santosa F, Moysidis T, Moerchel C, Kröger K, Bufe A (2014) Pulmonary embolism in young people. Trends in Germany from 2005 to 2011. Hämostaseologie 34:88–92CrossRefPubMed Santosa F, Moysidis T, Moerchel C, Kröger K, Bufe A (2014) Pulmonary embolism in young people. Trends in Germany from 2005 to 2011. Hämostaseologie 34:88–92CrossRefPubMed
3.
Zurück zum Zitat Wiener RS, Schwartz LM, Woloshin S (2013) When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ 347:f3368CrossRefPubMedPubMedCentral Wiener RS, Schwartz LM, Woloshin S (2013) When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ 347:f3368CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Tsai J, Grosse SD, Grant AM, Hooper WC, Atrash HK (2012) Trends in in-hospital deaths among hospitalizations with pulmonary embolism. Arch Intern Med 172:960–961CrossRefPubMed Tsai J, Grosse SD, Grant AM, Hooper WC, Atrash HK (2012) Trends in in-hospital deaths among hospitalizations with pulmonary embolism. Arch Intern Med 172:960–961CrossRefPubMed
5.
Zurück zum Zitat Wiener RS, Schwartz LM, Woloshin S (2011) Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 171:831–837PubMedPubMedCentral Wiener RS, Schwartz LM, Woloshin S (2011) Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 171:831–837PubMedPubMedCentral
6.
Zurück zum Zitat Syed FF, Beeching NJ (2005) Lower-limb deep-vein thrombosis in a general hospital: risk factors, outcomes and the contribution of intravenous drug use. QJM 98:139–145CrossRefPubMed Syed FF, Beeching NJ (2005) Lower-limb deep-vein thrombosis in a general hospital: risk factors, outcomes and the contribution of intravenous drug use. QJM 98:139–145CrossRefPubMed
7.
Zurück zum Zitat Moores L, Bilello KL, Murin S (2004) Sex and gender issues and venous thromboembolism. Clin Chest Med 25:281–297CrossRefPubMed Moores L, Bilello KL, Murin S (2004) Sex and gender issues and venous thromboembolism. Clin Chest Med 25:281–297CrossRefPubMed
9.
Zurück zum Zitat Eichinger S, Evers JL, Glasier A, La Vecchia C, Martinelli I, Skouby S, Somigliana E, Baird DT, Benagiano G, Crosignani PG, Gianaroli L, Negri E, Volpe A, Glasier A, Crosignani PG (2013) ESHRE Capri Workshop Group. Venous thromboembolism in women: a specific reproductive health risk. Hum Reprod Update 19:471–482CrossRef Eichinger S, Evers JL, Glasier A, La Vecchia C, Martinelli I, Skouby S, Somigliana E, Baird DT, Benagiano G, Crosignani PG, Gianaroli L, Negri E, Volpe A, Glasier A, Crosignani PG (2013) ESHRE Capri Workshop Group. Venous thromboembolism in women: a specific reproductive health risk. Hum Reprod Update 19:471–482CrossRef
10.
Zurück zum Zitat Dinger J, Assmann A, Möhner S, Minh TD (2010) Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J Fam Plann Reprod Health Care 36:123–129CrossRefPubMed Dinger J, Assmann A, Möhner S, Minh TD (2010) Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J Fam Plann Reprod Health Care 36:123–129CrossRefPubMed
11.
Zurück zum Zitat Sehovic N, Smith KP (2010) Risk of venous thromboembolism with drospirenone in combined oral contraceptive products. Ann Pharmacother 44:898–903CrossRefPubMed Sehovic N, Smith KP (2010) Risk of venous thromboembolism with drospirenone in combined oral contraceptive products. Ann Pharmacother 44:898–903CrossRefPubMed
12.
Zurück zum Zitat Jick SS, Hernandez RK (2011) Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ 342:d2151.CrossRefPubMedPubMedCentral Jick SS, Hernandez RK (2011) Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ 342:d2151.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Parkin L, Sharples K, Hernandez RK, Jick SS (2011) Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ 342:d2139CrossRefPubMedPubMedCentral Parkin L, Sharples K, Hernandez RK, Jick SS (2011) Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ 342:d2139CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Bird ST, Delaney JA, Etminan M, Brophy JM, Hartzema AG (2013) Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol? J Thromb Haemost 11:1059–1068CrossRefPubMed Bird ST, Delaney JA, Etminan M, Brophy JM, Hartzema AG (2013) Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol? J Thromb Haemost 11:1059–1068CrossRefPubMed
15.
Zurück zum Zitat Lidegaard Ø, Milsom I, Geirsson RT, Skjeldestad FE (2012) Hormonal contraception and venous thromboembolism. Acta Obstet Gynecol Scand 9:769–778CrossRef Lidegaard Ø, Milsom I, Geirsson RT, Skjeldestad FE (2012) Hormonal contraception and venous thromboembolism. Acta Obstet Gynecol Scand 9:769–778CrossRef
Metadaten
Titel
Disproportional increase of pulmonary embolism in young females in Germany: trends from 2005 to 2014
verfasst von
F. Santosa
Ch. Moerchel
Ch. Berg
K. Kröger
Publikationsdatum
20.02.2017
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 3/2017
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-017-1486-0

Weitere Artikel der Ausgabe 3/2017

Journal of Thrombosis and Thrombolysis 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.